000			01763 a2200505 4500
005			20250515234847.0
264		0	_c20110414
008			201104s 0 0 eng d
022			_a1423-0259
024	7		_a10.1159/000313985 _2doi
040			_aNLM _beng _cNLM
100	1		_aKamalden, T A
245	0	0	_aGenistein blunts the negative effect of ischaemia to the retina caused by an elevation of intraocular pressure. _h[electronic resource]
260			_bOphthalmic research _c2011
300			_a65-72 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aCaspase 3 _xgenetics
650	0	4	_aCaspase 8 _xgenetics
650	0	4	_aCyclophilins _xgenetics
650	0	4	_aDisease Models, Animal
650	0	4	_aFemale
650	0	4	_aFluorescent Antibody Technique, Indirect
650	0	4	_aGenistein _xtherapeutic use
650	0	4	_aGlial Fibrillary Acidic Protein _xmetabolism
650	0	4	_aInjections, Intraperitoneal
650	0	4	_aIntraocular Pressure
650	0	4	_aNeurofilament Proteins _xgenetics
650	0	4	_aOcular Hypertension _xcomplications
650	0	4	_aPhytoestrogens _xtherapeutic use
650	0	4	_aPoly Adenosine Diphosphate Ribose _xgenetics
650	0	4	_aProteins _xgenetics
650	0	4	_aRNA, Messenger _xgenetics
650	0	4	_aRats
650	0	4	_aRats, Wistar
650	0	4	_aReperfusion Injury _xetiology
650	0	4	_aRetinal Diseases _xetiology
650	0	4	_aReverse Transcriptase Polymerase Chain Reaction
650	0	4	_aThy-1 Antigens _xgenetics
700	1		_aJi, D
700	1		_aFawcett, R J
700	1		_aOsborne, N N
773	0		_tOphthalmic research _gvol. 45 _gno. 2 _gp. 65-72
856	4	0	_uhttps://doi.org/10.1159/000313985 _zAvailable from publisher's website
999			_c20050447 _d20050447